PSB-1434

CAS No. 1619884-65-9

PSB-1434( PSB 1434 | PSB1434 )

Catalog No. M27788 CAS No. 1619884-65-9

PSB-1434 is a selective and competitive monoamine oxidase B inhibitor with IC50 of 1.59 nM, selectivity versus MAO-A>6000-fold.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 Get Quote
10MG 447 Get Quote
25MG 714 Get Quote
50MG 1017 Get Quote
100MG 1368 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PSB-1434
  • Note
    Research use only, not for human use.
  • Brief Description
    PSB-1434 is a selective and competitive monoamine oxidase B inhibitor with IC50 of 1.59 nM, selectivity versus MAO-A>6000-fold.
  • Description
    PSB-1434 is a selective and competitive monoamine oxidase B inhibitor with IC50 of 1.59 nM, selectivity versus MAO-A>6000-fold.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PSB 1434 | PSB1434
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MAO
  • Recptor
    P-gp
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1619884-65-9
  • Formula Weight
    273.243
  • Molecular Formula
    C14H9F2N3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Fc1ccc(NC(=O)c2ccc3[nH]ncc3c2)cc1F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Qiu Q, et al. Design, Synthesis, and Pharmacological Characterization of N-(4-(2 (6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)yl)ethyl)phenyl)quinazolin-4-amine Derivatives: Novel Inhibitors Reversing P-Glycoprotein-Mediated Multidrug Resistance. J Med Chem. 2017 Apr 27;60(8):3289-3302.
molnova catalog
related products
  • hMAO-B-IN-5

    hMAO-B-IN-5 is a potent reversible and selective human monoamine oxidase hMAO-B inhibitor (IC50:0.12μM).

  • 2-Pentylfuran

    Flavouring ingredient.

  • Rasagiline Mesylate

    Rasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.